LEP-ETU FDA Approval Status
FDA Approved: No
Brand name: LEP-ETU
Generic name: Liposome Entrapped Paclitaxel
Company: Insys Therapeutics, Inc.
Treatment for: Ovarian Cancer
LEP-ETU (liposome entrapped paclitaxel) is an easy-to-use (ETU) liposomal formulation of paclitaxel (Taxol) in development for the treatment of ovarian cancer.
Development timeline for LEP-ETU
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
